Innovative Cell Technologies
Innovative Cell Technologies (ICT) is a U.S.-based company specializing in the development and manufacture of high-quality reagents for cell culture and life science research. Founded in San Diego, ICT operates under an ISO 13485:2016 quality system and is best known as the exclusive global manufacturer of Accutase® and Accumax™, two essential cell dissociation solutions that have become trusted alternatives to traditional trypsin.
Accutase® is a ready-to-use, gentle enzyme formulation for detaching adherent cells from culture vessels. It preserves surface proteins and cell viability, making it ideal for delicate cell types such as stem cells, iPSCs, and neurons. Trypsin-free and non-mammalian, it combines protease and collagenolytic activity, simplifying workflows and eliminating the need for serum neutralization.
Accumax™ is formulated for cell and tissue dissociation, efficiently breaking up aggregates and producing uniform single-cell suspensions. With protease, collagenolytic, and DNase activity, it is widely used in flow cytometry, viral transfection assays, and 3D culture applications.
ICT also offers AccutaseGMP (GMP-grade for clinical use) and AccutaseLZ, a lyophilized version for easy global shipping. Together, these innovations make ICT a key partner in advancing consistent, high-viability cell culture research worldwide.
